Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-10-26 Sale |
2021-10-28 7:48 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
2,739 | $73.6 | $201,590 | 55,853 (Direct) |
View |
2021-08-02 Sale |
2021-08-04 4:59 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
5,518 | $76.69 | $423,175 | 58,590 (Direct) |
View |
2021-05-10 Sale |
2021-05-12 7:21 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
8,513 | $77.29 | $657,970 | 551,372 (Indirect Direct) |
View |
2021-05-07 Sale |
2021-05-11 7:42 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
6,709 | $79.5 | $533,366 | 31,357 (Direct) |
View |
2021-05-06 Sale |
2021-05-10 9:07 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
50,000 | $78.21 | $3,910,319 | 593,398 (Indirect Direct) |
View |
2021-05-06 Sale |
2021-05-07 7:48 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director |
5,068 | $78.38 | $397,245 | 94,272 (Direct) |
View |
2021-05-03 Sale |
2021-05-04 8:27 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
4,673 | $78.3 | $365,896 | 64,108 (Direct) |
View |
2021-04-22 Sale |
2021-04-26 8:44 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
20,000 | $79.13 | $1,582,500 | 677,057 (Indirect Direct) |
View |
2021-04-19 Sale |
2021-04-20 9:53 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
2,709 | $79.58 | $215,582 | 68,440 (Direct) |
View |
2021-04-15 Sale |
2021-04-19 4:09 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $76.9 | $576,750 | 18,850 (Direct) |
View |
2021-04-08 Sale |
2021-04-09 5:57 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,537 | $78.81 | $121,131 | 58,250 (Direct) |
View |
2021-04-01 Sale |
2021-04-02 7:35 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
5,692 | $76.3 | $434,300 | 31,016 (Direct) |
View |
2021-03-30 Sale |
2021-04-01 2:17 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,652 | $74.79 | $123,553 | 59,787 (Direct) |
View |
2021-03-24 Sale |
2021-03-26 5:45 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,181 | $76.3 | $90,110 | 61,439 (Direct) |
View |
2021-03-18 Sale |
2021-03-19 9:01 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,308 | $77.99 | $102,011 | 64,133 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-04-30 Option Award |
2021-10-28 7:48 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
342 | $62.41 | 55,853 (Direct) |
View |
2021-10-20 Exercise |
2021-10-22 4:36 pm |
2012-11-08 2022-05-07 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $0 | 690,372 (Direct) |
View |
2021-10-20 Exercise |
2021-10-22 4:36 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $37.46 | 690,372 (Direct) |
View |
2021-07-16 Tax Withholding |
2021-07-19 8:55 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Acosta Andrea GVP, Chief Accounting Officer |
285 | $78.84 | 18,122 (Direct) |
View |
2021-04-30 Option Award |
2021-07-19 8:55 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Acosta Andrea GVP, Chief Accounting Officer |
271 | $62.41 | 18,122 (Direct) |
View |
2021-06-29 Tax Withholding |
2021-06-30 8:18 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
576 | $83.46 | 30,781 (Direct) |
View |
2021-06-21 Exercise |
2021-06-23 5:04 pm |
2012-11-08 2022-05-07 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $0 | 690,372 (Direct) |
View |
2021-06-21 Exercise |
2021-06-23 5:04 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $37.46 | 690,372 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 8:44 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director |
5,120 | $0 | 28,035 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 8:05 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | PYOTT DAVID E I Director |
5,120 | $0 | 35,860 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 7:29 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director |
5,120 | $0 | 99,392 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 7:02 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
5,120 | $0 | 23,970 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 6:34 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | HOMBACH ROBERT J. Director |
5,120 | $0 | 21,330 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 5:57 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ho Maykin Director |
5,120 | $0 | 7,470 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 5:37 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | HERON ELAINE J Director |
5,120 | $0 | 72,088 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 5:20 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Dere Willard H Director |
5,120 | $0 | 18,410 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 4:12 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | ANDERSON ELIZABETH M Director |
5,120 | $0 | 13,910 (Direct) |
View |
2021-05-10 Exercise |
2021-05-12 7:21 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
8,513 | $0 | 551,372 (Direct) |
View |
2021-05-10 Exercise |
2021-05-12 7:21 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
8,513 | $26.49 | 551,372 (Direct) |
View |
2021-05-07 Exercise |
2021-05-11 7:42 pm |
2011-12-01 2021-05-30 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
6,709 | $0 | 31,357 (Direct) |
View |
2021-05-07 Exercise |
2021-05-11 7:42 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
6,709 | $28.23 | 31,357 (Direct) |
View |
2021-04-30 Option Award |
2021-05-11 7:42 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
341 | $62.41 | 31,357 (Direct) |
View |
2021-05-06 Exercise |
2021-05-10 9:07 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
50,000 | $0 | 593,398 (Direct) |
View |
2021-05-06 Exercise |
2021-05-10 9:07 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
50,000 | $26.49 | 593,398 (Direct) |
View |
2021-04-30 Option Award |
2021-05-10 9:07 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
341 | $62.41 | 593,398 (Direct) |
View |
2021-05-06 Exercise |
2021-05-07 7:48 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director |
15,000 | $0 | 94,272 (Direct) |
View |
2021-05-06 Exercise |
2021-05-07 7:48 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director |
15,000 | $26.49 | 94,272 (Direct) |
View |
2021-05-04 Tax Withholding |
2021-05-05 8:46 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
3,986 | $78.35 | 41,695 (Direct) |
View |
2021-04-30 Option Award |
2021-05-05 8:46 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
221 | $62.41 | 41,695 (Direct) |
View |
2021-04-30 Option Award |
2021-05-04 8:27 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
341 | $62.41 | 64,108 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 8:24 pm |
2012-11-08 2022-05-07 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $0 | 690,031 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 8:24 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
1,000 | $37.46 | 690,031 (Direct) |
View |
2021-04-22 Exercise |
2021-04-26 8:44 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
20,000 | $0 | 677,057 (Direct) |
View |
2021-04-22 Exercise |
2021-04-26 8:44 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
20,000 | $26.49 | 677,057 (Direct) |
View |
2021-04-19 Exercise |
2021-04-20 9:53 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
2,709 | $0 | 68,440 (Direct) |
View |
2021-04-19 Exercise |
2021-04-20 9:53 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
2,709 | $26.49 | 68,440 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 4:09 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $0 | 18,850 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 4:09 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $26.49 | 18,850 (Direct) |
View |
2021-03-22 Tax Withholding |
2021-03-23 9:22 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
516 | $78.52 | 36,708 (Direct) |
View |
2021-03-22 Tax Withholding |
2021-03-23 9:12 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
2,454 | $78.52 | 106,142 (Direct) |
View |
2021-03-22 Tax Withholding |
2021-03-23 9:00 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
1,391 | $78.52 | 68,440 (Direct) |
View |
2021-03-22 Tax Withholding |
2021-03-23 8:50 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Chief Executive Officer |
5,519 | $78.52 | 550,031 (Direct) |
View |
2021-03-22 Tax Withholding |
2021-03-23 8:40 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,513 | $78.52 | 62,620 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 9:42 pm |
2022-03-15 2031-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
36,070 | $0 | 71,110 (Direct) |
View |
2021-03-15 Tax Withholding |
2021-03-17 9:39 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
994 | $78.39 | 62,114 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 9:39 pm |
2022-03-15 2031-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
35,000 | $0 | 62,114 (Direct) |
View |
2021-03-16 Tax Withholding |
2021-03-17 9:39 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
582 | $77.21 | 62,114 (Direct) |
View |
2021-03-15 Tax Withholding |
2021-03-17 9:35 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
5,014 | $78.39 | 95,481 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 9:35 pm |
2022-03-15 2031-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
36,070 | $0 | 95,481 (Direct) |
View |
2021-03-16 Tax Withholding |
2021-03-17 9:35 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, General Counsel |
1,252 | $77.21 | 95,481 (Direct) |
View |
2021-03-15 Tax Withholding |
2021-03-17 9:31 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
7,460 | $78.39 | 146,306 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 9:31 pm |
2022-03-15 2031-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
53,030 | $0 | 146,306 (Direct) |
View |
2021-03-16 Tax Withholding |
2021-03-17 9:31 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
2,259 | $77.21 | 146,306 (Direct) |
View |
2021-03-15 Tax Withholding |
2021-03-17 9:27 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
5,273 | $78.39 | 91,841 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 9:27 pm |
2022-03-15 2031-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
37,120 | $0 | 91,841 (Direct) |
View |
2021-03-16 Tax Withholding |
2021-03-17 9:27 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
1,287 | $77.21 | 91,841 (Direct) |
View |